[144] ACM Research, Inc. SEC Filing
ACM Research (ACMR) Form 144 notice reports a proposed sale of 60,000 common shares through Morgan Stanley Smith Barney on 09/04/2025 with an aggregate market value of $1,586,508.00. The shares were acquired and to be sold following a stock option exercise on 09/04/2025 and payment was made in cash. The filing notes 64,180,965 shares outstanding. It also discloses a recent sale by Hui Wang of 70,000 shares on 09/03/2025 for $1,873,711.00. The filer certifies they are not aware of any undisclosed material adverse information.
- Disclosure includes acquisition details: the filing specifies the shares were acquired via a stock option exercise on 09/04/2025 and paid in cash.
- Brokered transaction: the proposed sale is routed through Morgan Stanley Smith Barney, providing a clear execution venue.
- Insider selling shares: the filing shows a proposed sale of 60,000 common shares, which is a notable insider disposition.
- Recent sizable prior sale: the filer disclosed a 70,000-share sale on 09/03/2025 for $1,873,711.00, indicating recent insider selling activity.
Insights
TL;DR: Routine insider sale following option exercise; amount disclosed but no operational or financial details changed.
The filing documents a proposed sale of 60,000 ACMR shares executed via a stock option exercise and routed through Morgan Stanley Smith Barney on 09/04/2025. The disclosed aggregate market value is $1,586,508.00 and the company has 64,180,965 shares outstanding. The filing also reports a prior sale of 70,000 shares on 09/03/2025 for $1,873,711.00. As a Form 144, this is a compliance notice required for resale by affiliates or persons deemed affiliates and does not by itself convey company performance metrics.
TL;DR: Form 144 appears complete for the proposed sale; includes required acquisition and recent-sale disclosures.
The notice includes the nature of acquisition (stock option exercise), payment method (cash), broker details, and prior sales within three months, aligning with Rule 144 disclosure obligations. The signer represents absence of undisclosed material adverse information. The document contains no additional operational or financial data and does not indicate regulatory or legal concerns based on the provided text.